Clinical Data Summary
The collection of clinical data is ongoing. UVLrx Therapeutics™ is currently involved in numerous clinical studies around the world. Although we are committed to developing a technology to treat blood-borne pathogens, we see many other therapeutic applications for the UVLrx System™.
As it stands, many of the trials have focused on simply improving quality of life for many patients suffering with chronic diseases, such as Lyme Disease, Hepatitis, and chronic infections. There are many regulatory pathways that we must navigate before any specific claim of safety and efficacy can be made regarding the outcome of a specific disease.
Accordingly, the data presented here focuses on general well being of patients with specific chronic conditions.
|Acute Cold/Flu||Reduction in cold related symptoms and recovery support|
|Chronic Fatigue||Improvement in energy and focus|
|Chronic Lyme Disease||Improvement in mental focus and clarity|
|Epstein Barr Virus||Improvement in overall well-being|
|Hepatitis C||Improvement in general well-being and focus|
Sometimes, an improvement in quality of life can be a powerful milestone for a chronic patient. With that said UVLrx Therapeutics™ remains dedicated to finding therapeutic solutions, to not only treat specific diseases, but to help restore something most cherished by chronically-ill patients: quality of life.